Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments

被引:0
|
作者
Seungyong Shin
Jiyoung Lee
Jieun Han
Fangyuan Li
Daishun Ling
Wooram Park
机构
[1] The Catholic University of Korea,Department of Biomedical
[2] The Catholic University of Korea,Chemical Engineering and Biotechnology
[3] Zhejiang University,Department of Biotechnology
[4] Zhejiang University,Institute of Pharmaceutics, College of Pharmaceutical Sciences
[5] Shanghai Jiao Tong University,Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences
关键词
Tumor microenvironment; Nanoparticles; Cancer treatments; Drug delivery; Biomaterials;
D O I
暂无
中图分类号
学科分类号
摘要
Cancer is one of the major diseases that threaten human life worldwide. Despite advances in cancer treatment techniques, such as radiation therapy, chemotherapy, targeted therapy, and immunotherapy, it is still difficult to cure cancer because of the resistance mechanism of cancer cells. Current understanding of tumor biology has revealed that resistance to these anticancer therapies is due to the tumor microenvironment (TME) represented by hypoxia, acidity, dense extracellular matrix, and immunosuppression. This review demonstrates the latest strategies for effective cancer treatment using functional nanoparticles that can modulate the TME. Indeed, preclinical studies have shown that functional nanoparticles can effectively modulate the TME to treat refractory cancer. This strategy of using TMEs with controllable functional nanoparticles is expected to maximize cancer treatment efficiency in the future by combining it with various modern cancer therapeutics.
引用
收藏
页码:205 / 219
页数:14
相关论文
共 50 条
  • [1] Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments
    Shin, Seungyong
    Lee, Jiyoung
    Han, Jieun
    Li, Fangyuan
    Ling, Daishun
    Park, Wooram
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2022, 19 (02) : 205 - 219
  • [2] Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment
    Li, Ji
    Zhao, Ming
    Sun, Meng
    Wu, Siwen
    Zhang, Hongyan
    Dai, Yinghui
    Wang, Dongkai
    ACS APPLIED MATERIALS & INTERFACES, 2020, 12 (45) : 50734 - 50747
  • [3] Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
    Yang, Shu
    Gao, Huile
    PHARMACOLOGICAL RESEARCH, 2017, 126 : 97 - 108
  • [4] Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy
    Xu, Tianyue
    Liu, Zhihui
    Huang, Liwen
    Jing, Jing
    Liu, Xiaowei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] Boosting antitumor efficacy of nanoparticles by modulating tumor mechanical microenvironment
    Zhang, Xiaoqiong
    Zhang, Xiaojuan
    Yong, Tuying
    Gan, Lu
    Yang, Xiangliang
    EBIOMEDICINE, 2024, 105
  • [6] Elucidation of tumor microenvironment for new cancer treatments
    Miyazono, Kohei
    Saya, Hideyuki
    CANCER SCIENCE, 2018, 109 : 181 - 181
  • [7] Nanoparticles Modulating the Immune Microenvironment in Breast Cancer Treatment
    Guo, Li-Juan
    Wu, Jinsheng
    Lu, Weifeng
    Li, Jing
    Wang, Yeling
    Yang, Hui
    Wang, Tian-Zhu
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2025, 20 : 1367 - 1382
  • [8] Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment
    Zhang, Yinlong
    Ho, Shih-Hsin
    Li, Bozhao
    Nie, Guangjun
    Li, Suping
    MEDICINAL RESEARCH REVIEWS, 2020, 40 (03) : 1084 - 1102
  • [9] Tumor microenvironment: recent advances in various cancer treatments
    Wang, J. -J.
    Lei, K. -F.
    Han, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (12) : 3855 - 3864
  • [10] Effective Targeting of the Tumor Microenvironment for Cancer Therapy
    Jiang, Ping
    Li, Xiaoming
    Thompson, Curtis B.
    Huang, Zhongdong
    Araiza, Flavio
    Osgood, Ryan
    Wei, Ge
    Feldmann, Marc
    Frost, Gregory I.
    Shepard, H. Michael
    ANTICANCER RESEARCH, 2012, 32 (04) : 1203 - 1212